Law firm investigates HCA Healthcare after stock drops on lowered 2026 profit forecast

Bragar Eagel & Squire, P.C. is investigating HCA Healthcare on behalf of stockholders following HCA's announcement of a lowered full-year 2026 profit guidance due to an unfavorable payer mix that reduced revenue by about $400 million in Q2. This news caused HCA's stock to drop nearly 7% on July 14, 2026. The investigation aims to determine if HCA violated securities laws or engaged in unlawful business practices. Investors who suffered losses or have information are encouraged to contact the law firm for potential legal action.